Treatment overview
Morpheus8 treatment at Olive Skin & Aesthetics combines microneedling with fractional radiofrequency energy to remodel tissue at a subdermal level. We use this FDA-cleared device to address skin laxity, textural irregularities, and stubborn fat pockets — delivering results that surpass conventional microneedling alone.
By penetrating up to 4 mm deep, Morpheus8 stimulates collagen and elastin production while contouring underlying adipose tissue. The outcome is tighter, smoother skin with improved tone, reduced scarring, and a more sculpted appearance.
- Adults with moderate skin laxity and textural concerns on the face, neck, or body
- Individuals with deep acne scars or stretch marks unresponsive to superficial treatments
- Patients seeking contouring of small fat deposits under the chin or along the jawline
- Those who want the benefits of both microneedling and radiofrequency in a single device
- People of all skin tones — the colour-blind technology carries minimal risk of hyperpigmentation
Topical anaesthetic cream is applied for 30–45 minutes before treatment. The session takes 30–60 minutes depending on the number of areas treated. The handpiece delivers coated microneedles that emit radiofrequency energy at programmable depths.
our team customises needle depth (0.5–4 mm) and energy levels for each anatomical zone, using burst mode for fat remodelling and fixed mode for collagen tightening. Multiple passes at varying depths create a three-dimensional scaffolding effect for comprehensive tissue renewal.
- Immediately after: Pinpoint bleeding and redness with a grid-like pattern; skin feels warm and tight.
- Day 1–3: Redness and mild swelling resembling sunburn; micro-crusts form at needle entry points.
- Day 4–5: Micro-crusts shed; skin may appear bronzed or slightly rough as it heals.
- Week 1–2: Skin normalises; early improvements in texture and tightness become visible.
- Month 1–3: Collagen remodelling peaks; continued firming, scar improvement, and contouring develop. A second session may be performed at 4–6 weeks.
real patients
